ImmunoGen, Inc. (IMGN) Social Stream
IMMUNOGEN INC (IMGN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMGN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 7 | $12 | $5 | $7.9 | $14.93 | -47.09% |
| 2021-12-01 | 7 | $12 | $5 | $8.9 | $14.93 | -40.39% |
| 2022-02-02 | 7 | $12 | $6.5 | $9.3 | $14.93 | -37.71% |
| 2022-02-11 | 8 | $18 | $6.5 | $10.75 | $14.93 | -28% |
| 2022-03-09 | 8 | $18 | $5 | $10.416 | $14.93 | -30.23% |
| 2022-03-20 | 9 | $18 | $5 | $10.416 | $14.93 | -30.23% |
| 2022-03-21 | 9 | $18 | $5 | $9.642 | $14.93 | -35.42% |
| 2022-05-06 | 9 | $18 | $5 | $9.571 | $14.93 | -35.89% |
| 2022-08-01 | 9 | $18 | $4 | $9.666 | $14.93 | -35.26% |
| 2022-08-10 | 9 | $18 | $4 | $9.428 | $14.93 | -36.85% |
| 2022-08-31 | 9 | $18 | $4 | $9.285 | $14.93 | -37.81% |
| 2022-09-09 | 9 | $18 | $4 | $9.125 | $14.93 | -38.88% |
| 2022-11-07 | 10 | $18 | $4 | $9.125 | $14.93 | -38.88% |
| 2022-11-15 | 10 | $18 | $4 | $9.25 | $14.93 | -38.04% |
| 2022-11-16 | 11 | $20 | $4 | $11 | $14.93 | -26.32% |
| 2022-11-28 | 12 | $20 | $4 | $10.9 | $14.93 | -26.99% |
| 2023-01-05 | 12 | $19.001 | $4 | $10.4 | $14.93 | -30.34% |
| 2023-02-27 | 12 | $19.001 | $4 | $10.5 | $14.93 | -29.67% |
| 2023-03-02 | 12 | $19.001 | $3 | $10.4 | $14.93 | -30.34% |
| 2023-04-28 | 11 | $19.001 | $3 | $10.889 | $14.93 | -27.07% |
| 2023-05-01 | 11 | $19.001 | $3 | $11 | $14.93 | -26.32% |
| 2023-05-03 | 11 | $19.001 | $5 | $13.222 | $14.93 | -11.44% |
| 2023-05-09 | 11 | $19.001 | $8 | $13.555 | $14.93 | -9.21% |
| 2023-06-05 | 11 | $19.001 | $8 | $13.889 | $14.93 | -6.97% |
| 2023-06-06 | 11 | $19.001 | $8 | $14.333 | $14.93 | -4% |
| 2023-06-13 | 11 | $21 | $8 | $16.222 | $14.93 | 8.65% |
| 2023-06-16 | 11 | $24 | $8 | $17.111 | $14.93 | 14.61% |
| 2023-07-18 | 11 | $24 | $8 | $18 | $14.93 | 20.56% |
| 2023-07-27 | 11 | $24 | $8 | $18.444 | $14.93 | 23.54% |
| 2023-08-01 | 11 | $24 | $8 | $19 | $14.93 | 27.26% |
| 2023-08-02 | 11 | $27 | $9.001 | $22 | $14.93 | 47.35% |
| 2023-08-29 | 11 | $27 | $9.001 | $22.111 | $14.93 | 48.1% |
| 2023-09-13 | 11 | $27 | $13 | $23.555 | $14.93 | 57.77% |
The Trend in the Analyst Price Target
IMGN's average price target has moved up $14.25 over the prior 22 months.
IMGN reports an average of 75.4% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-15 | 10 | 18.000 | 4.000 | 9.250 | 5.01 | 84.63% |
| 2023-01-23 | 12 | 19.001 | 4.000 | 10.500 | 4.66 | 125.32% |
| 2023-03-02 | 12 | 19.001 | 3.000 | 10.889 | 4.45 | 144.7% |
| 2023-05-09 | 11 | 19.001 | 8.000 | 13.555 | 13.75 | -1.42% |
| 2023-08-02 | 11 | 27.000 | 9.001 | 22.000 | 17.17 | 28.13% |
IMGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.18 | 10 | 0 | 1 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
IMGN's average broker recommendation rating improved by 0.62 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, IMMUNOGEN INC's upside potential (average analyst target price relative to current price) is greater than 495.23% of them.
- IMGN has a lower variance in analysts' estimates than -3165.75% of all US stocks.
- IMMUNOGEN INC's average analyst price target is greater than 556.5% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, IMMUNOGEN INC's number of analysts covering the stock is greater than 2711.25% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IMMUNOGEN INC are HRTX, ADCT, and ROIV.
View All Top Stocks by Price Target
Make investment decisions regarding IMGN using the data that counts. Try POWR Ratings for free.